Does MEPOLIZUMAB Cause Lung neoplasm malignant? 233 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 233 reports of Lung neoplasm malignant have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.5% of all adverse event reports for MEPOLIZUMAB.
233
Reports of Lung neoplasm malignant with MEPOLIZUMAB
0.5%
of all MEPOLIZUMAB reports
7
Deaths
115
Hospitalizations
How Dangerous Is Lung neoplasm malignant From MEPOLIZUMAB?
Of the 233 reports, 7 (3.0%) resulted in death, 115 (49.4%) required hospitalization, and 2 (0.9%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 233 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which MEPOLIZUMAB Alternatives Have Lower Lung neoplasm malignant Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE